Álvaro Castellanos | Medicine | Innovation in Education Excellence Award

Assoc. Prof. Dr. Álvaro Castellanos | Medicine | Innovation in Education Excellence Award

Assoc. Prof. Dr. Álvaro Castellanos, HOSPITAL UNIVERSITARIO Y POLITÉCNICO LA FE DE VALENCIA, Spain

Dr. Álvaro Castellanos Ortega is a highly esteemed Associate Professor of Medicine and the Head of the Intensive Care Department at Hospital Universitario y Politécnico La Fe in Valencia. He earned his Medical degree from the University of Valladolid and completed his PhD at the University of Cantabria. With extensive expertise in intensive care and medical education, Dr. Castellanos has contributed significantly to research in infection, sepsis, and training. He has authored 63 indexed publications, and his work on competence-based medical education has earned multiple prestigious awards, including the ESICM Trials Group Award. He is also actively involved in European medical education initiatives.

Publication Profile

Orcid

Professional Qualifications 🏥

Assoc. Prof. Dr. Álvaro Castellanos is a distinguished medical professional with a strong academic and clinical background. He graduated in Medicine and Surgery from the University of Valladolid (1979) and earned his PhD with honors from the University of Cantabria (1998), focusing on a prognostic scoring system for meningococcal septic shock in children. He specialized in Intensive Care Medicine, completing his training at Hospital Universitario Marqués de Valdecilla. Dr. Castellanos serves as Head of the Intensive Care Medicine Department at Hospital Universitario y Politécnico La Fe de Valencia. He is also an Associate Professor at the University of Valencia and an EDIC examiner. Additionally, he holds a Master’s in Healthcare Administration from the University of Cantabria. 🌟

 

 

Awards and Recognitions

Assoc. Prof. Dr. Álvaro Castellanos has earned numerous prestigious awards throughout his career. He won the First Prize for Quality Improvement of Care from the Regional Healthcare Service of Cantabria in 2008. His initiative on implementing the Surviving Sepsis Campaign during residency also received recognition. In 2017, he earned the First Prize for Best Patient Safety Initiatives for his rapid response system project. Dr. Castellanos was awarded the Best Project in Postgraduate Teaching by the Lilly Foundation for his electronic portfolio for specialists. Additionally, he received the ESICM Trials Group Award for his research on medical education in intensive care. 🌟

 

 

Research Focus

Dr. Álvaro Castellanos-Ortega is an Associate Professor with significant contributions in intensive care medicine, particularly related to medical education and patient safety in critically ill patients. He has been involved in multiple research projects focusing on pharmacokinetics in critically ill patients, including studies on Cefiderocol, Isavuconazole, and other medications. Dr. Castellanos-Ortega has authored and co-authored numerous articles on intensive care topics such as COVID-19 management, heart transplantation, and training programs for intensive care medicine. His work is widely published in journals like Medicina Intensiva and Critical Care, contributing significantly to the improvement of clinical practices in intensive care units.

 

 

Publication Top Notes

  • Effect of a Competence-Based Medical Education Program on Training Quality in Intensive Care Medicine. COBALIDATION TRIAL.
    Medicina Intensiva (2025-01-03)
    DOI: 10.1016/j.medine.2024.502126
    PMID: 39755447
    Contributors: Castellanos-Ortega Á, Broch Porcar MJ, Palacios-Castañeda D, et al.
  • Cefiderocol Pharmacokinetics in Critically Ill Patients Undergoing ECMO Support.
    Critical Care (2024-10-18)
    DOI: 10.1186/s13054-024-05126-4
    PMID: 39425201
    PMC: PMC11488226
    Contributors: Marín-Cerezuela M, Martín-Latorre R, Frasquet J, et al.
  • Reply to “Patient Safety, What Does Clinical Simulation and Teaching Innovation Contribute?”
    Medicina Intensiva (2024-10-05)
    DOI: 10.1016/j.medine.2024.07.013
    PMID: 39368886
    Contributors: Broch Porcar MJ, Castellanos-Ortega Á
  • Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends Over Time.
    Biomedicines (2024-09-16)
    DOI: 10.3390/biomedicines12092109
    PMID: 39335622
    PMC: PMC11428817
    Contributors: López Vilella R, Pérez Guillén M, Borja Guerrero Cervera, et al.
  • Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
    Antibiotics (2024-07-29)
    DOI: 10.3390/antibiotics13080706
    PMID: 39200006
    PMC: PMC11350865
    Contributors: Martín Cerezuela M, Gallegos C, Marqués-Miñana MR, et al.
  • Patient Safety, What Does Clinical Simulation and Teaching Innovation Contribute?
    Medicina Intensiva (2024-05-25)
    DOI: 10.1016/j.medine.2024.04.012
    PMID: 38797620
    Contributors: Broch Porcar MJ, Castellanos-Ortega Á
  • “INTUPROS”: An Opportunity to Reflect Upon and Improve.
    Medicina Intensiva (2024-05-06)
    DOI: 10.1016/j.medine.2024.04.014
    PMID: 38714391
    Contributors: Viviani A, Vicent C, Castellanos-Ortega Á
  • Mentoring Programme: Guiding Your First Steps Towards Scientific Excellence.
    Medicina Intensiva (2023-03-21)
    DOI: 10.1016/j.medine.2023.03.006
    PMID: 36948924
    Contributors: Lobo-Valbuena B, Galarza Barrachina L, Albillos Almaraz R, et al.
  • Effects of Intubation Timing in Patients with COVID-19 Throughout the Four Waves of the Pandemic: A Matched Analysis.
    The European Respiratory Journal (2023-03-02)
    DOI: 10.1183/13993003.01426-2022
    PMID: 36396142
    PMC: PMC9686319
    Contributors: Riera del Brio J, Barbeta E, Tormos A, et al.
  • Driving Pressure and Adjunctive Therapies in Pulmonary Sequelae of COVID-19 Patients Under Invasive Ventilation.
    Intensive Care Medicine (2023-01-25)
    DOI: 10.1007/s00134-022-06951-3
    PMID: 36695836
    PMC: PMC9875751
    Contributors: González J, Iván David Benítez, Ana Motos, et al.

 

Vivien Jiaqian Zhu | Humanities | Best Researcher Award

Dr. Vivien Jiaqian Zhu | Humanities | Best Researcher Award

PhD at Stanford University and University of California, Berkeley, United States.

Vivien Jiaqian Zhu is a Ph.D. candidate at UC Berkeley and a visiting scholar at Stanford University, specializing in Japanese literature and art history. She has a diverse academic background, with studies spanning multiple prestigious institutions such as Harvard, Stanford, and Cambridge. Zhu’s research primarily focuses on East Asian languages and cultures, particularly on topics related to Japanese literature, art history, and the intersection of textuality and haptic aesthetics. She has demonstrated excellence through various honors, fellowships, and academic experiences, including her dissertation on the haptic beauty in Kawabata Yasunari’s works. Zhu has also presented at numerous international conferences and contributed significantly to the field through archival research, publications, and curatorial work.

Publication Profile

Orcid

Education 🎓

Vivien Jiaqian Zhu has pursued a diverse academic path across prestigious institutions. She is currently a Ph.D. candidate in Japanese Language and Literature at UC Berkeley, where she also received the Regent’s Fellowship. Her Master’s thesis focuses on Kawabata Yasunari’s works, exploring the tactile beauty in his Palm-of-the-Hand Stories. Zhu’s undergraduate studies at UC Berkeley culminated in an honors degree in Comparative Literature and Chinese Language, with a minor in the History of Art. She earned Phi Beta Kappa and other honors during her time at Berkeley. Zhu also studied advanced Japanese at the Inter-University Center for Japanese Language Studies in Yokohama and undertook language programs at Sophia University, Japan. Her academic pursuits also took her to Middlebury College and the Culinary Institute of America. At present, she is also studying Early Modern Japanese Palaeography at the University of Cambridge under the Mitsubishi Research Fellowship.

Experience 🩺

Vivien Jiaqian Zhu has accumulated extensive experience through her academic and professional roles. She is a visiting scholar at Stanford University, where she collaborates on research projects and participates in academic seminars. Zhu has also worked as a graduate student researcher at UC Berkeley, where she assisted in archival research and curated collections, focusing on Japanese literature and East Asian cultures. Her professional experience extends to editorial roles, including serving on the editorial board of the International Journal of Sustainable Fashion & Textile and as the editor of the Language & Theory section of Ling Mag. Zhu’s expertise is also reflected in her involvement in the International Joint Digital Center for Japanese Art and Culture at Ritsumeikan University. She has conducted research across various international libraries, including UC Berkeley, Nanjing University, and the University of Tokyo. Additionally, Zhu has gained teaching experience, particularly in Chinese calligraphy and East Asian studies.

Awards and Honors 🏅

Vivien Jiaqian Zhu’s academic excellence has been recognized through numerous prestigious awards and fellowships. In 2024, she received the Mitsubishi Research Fellowship for Early Modern Japanese Palaeography at the University of Cambridge, allowing her to study under the Emmanuel College at the university. Zhu has been honored with the Regent’s Fellowship for Graduate Study at UC Berkeley, nominated by Professor H. Mack Horton. She was awarded the CJS Graduate Student Fellowship, the UC Berkeley Departmental Award, and the Theresa Hak Kyung Cha Fellowship Award. Zhu’s academic recognition extends to memberships in Phi Beta Kappa and Golden Key International Honor Society. She has also earned multiple scholarships and fellowships, including the Nippon Foundation Fellowship for Japanese language studies at Stanford, the Dietrich von Bothmer Classical Scholarship, and the Institute of International Studies Undergraduate Merit Scholarship. Her research contributions have been consistently acknowledged, making her a prominent figure in East Asian literary studies.

Research Focus 🔬

Vivien Jiaqian Zhu’s research focuses on the intersection of Japanese literature, art history, and East Asian cultural studies. Her doctoral research at UC Berkeley explores the tactile and haptic elements in Kawabata Yasunari’s Palm-of-the-Hand Stories, examining how sensory experiences influence narrative structure and reader engagement. Zhu’s academic interests include the cultural and historical contexts of Japanese literature, with a particular emphasis on modern and early modern periods. She investigates the transnational connections between Japan, China, and the broader East Asian region, often incorporating interdisciplinary methodologies from comparative literature, art history, and cultural studies. Additionally, Zhu has worked on archival research projects, including studies of Chinese calligraphy, criminal law, and comparative law. Her studies in early modern Japanese palaeography and her deep engagement with East Asian art and literature reflect her broad intellectual interests, positioning her as a key scholar in understanding the intricate relationships between language, culture, and history in the region.

Conclusion

Vivien Jiaqian Zhu is an exceptionally talented researcher whose interdisciplinary approach and scholarly achievements make her an outstanding candidate for the Best Researcher Award. Her unique focus on the tactile aesthetics in Japanese literature and art, along with her academic excellence, make her stand out as a leader in her field. With a proven track record of global recognition and a commitment to advancing knowledge, Zhu’s continued contributions will undoubtedly have a lasting impact on the study of East Asian literature and art history.

Publication Top Notes 📚

  • “I Dwell in Possibility”: The Poetics of Space in the Works of 1980s Japanese Avant-Garde Fashion DesignersComparative Literature: East & West

    2024-12-08 | journal-article

    Source:Crossref

    DOI: 10.1080/25723618.2024.2433301

 

Hawraa Shbeeb | Medicine | Best Researcher Award

Dr. Hawraa Shbeeb | Medicine | Best Researcher Award

Fellowship in Infertility and IVF at Tehran University of Medical Sciences, Iran, Iran.

Dr. Hawraa Shbeeb is a dedicated Obstetrics and Gynecology Specialist currently pursuing a Fellowship in Infertility and IVF at Tehran University of Medical Sciences. She has significant international experience, registered as a specialist in both Iran and Lebanon, and is affiliated with several esteemed organizations like the Lebanese Society of Obstetrics and Gynecology (LSOG) and ISUGO. Her certifications demonstrate a commitment to continuous medical education, and she has contributed to research in infertility and reproductive health, with a recent publication in a peer-reviewed journal.

Publication Profile

Orcid

Education 🎓

Dr. Hawraa Shbeeb earned her Doctor of Medicine (MD) degree from Mashhad University of Medical Sciences (2009-2017). She specialized in Obstetrics and Gynecology at the same institution, completing her residency in December 2021. Currently, she is advancing her expertise through a Fellowship in Infertility and IVF at the prestigious Tehran University of Medical Sciences (2023-present). Her educational background also includes passing the Lebanese Colloquium Medicine Exam (2022), enabling her to practice in Lebanon. Her academic journey reflects a strong focus on women’s reproductive health, with an emphasis on infertility, assisted reproductive technologies, and high-risk pregnancies. Dr. Shbeeb’s pursuit of advanced certifications and continuous learning underscores her dedication to providing cutting-edge care in the field of reproductive medicine.

Experience 🩺

Dr. Hawraa Shbeeb has extensive experience as an Obstetrics and Gynecology Specialist. She has been practicing at the Imam Khomeini Hospital Complex in Tehran since January 2023. Previously, she served at the Imam Reza Hospital and Ghaem and Ommolbanin Hospitals in Mashhad, Iran (2017-2020). Dr. Shbeeb is also registered with the Lebanese Order of Physicians (LOP) and has been an active specialist in Lebanon since October 2022. Her affiliations with professional organizations like LSOG and ISUGO highlight her involvement in the global medical community. Additionally, she is a dedicated volunteer with the Iranian Red Crescent (2024-present), contributing to humanitarian efforts. Her experience spans clinical practice, research, and teaching, demonstrating a holistic approach to women’s healthcare.

Awards and Honors 🏅

Dr. Hawraa Shbeeb has earned multiple accolades for her contributions to healthcare and continuous education. She received the International Volunteer Day Award from the Iranian Red Crescent for her humanitarian work in Khorasan Razavi. Her certifications from esteemed bodies like ACOG, SAFOG, FOGSI, and the American Association for Continuous Education reflect her commitment to excellence in gynecology and reproductive health. Notable certifications include those in Minimal Access Surgery, Infertility & ARTs, Pregnancy Complications, and Fetal Medicine. She also holds certifications in Advanced Cardiac Life Support (ACLS), Pediatric Advanced Life Support (PALS), and Basic Life Support (BLS) from Medtigo Health Education. These honors underscore her dedication to patient care, continuous learning, and professional excellence.

Research Focus 🔬

Dr. Hawraa Shbeeb’s research focuses on the fields of infertility, assisted reproductive technology (ART), and high-risk pregnancies. Her work addresses rare and complex gynecological cases, particularly those involving ectopic pregnancies and complications arising from embryo transfer procedures. Through her recent fellowship, she delves into advanced infertility treatments, IVF protocols, and improving outcomes for couples facing reproductive challenges. Dr. Shbeeb is dedicated to exploring new frontiers in minimal-access gynecological surgery, fetal medicine, and pregnancy complications. Her goal is to bridge clinical practice and research to enhance patient care. Her published case report on cornual pregnancy highlights her commitment to identifying and addressing rare medical conditions, providing valuable insights to the medical community.

Conclusion

Dr. Hawraa Shbeeb is a strong candidate for the Best Researcher Award due to her extensive clinical expertise, dedication to infertility research, and international professional affiliations. Her recent publication and ongoing fellowship in IVF indicate active engagement with cutting-edge reproductive medicine. Strengthening her research output and focusing on collaborative projects can further solidify her standing as a distinguished researcher in her field.

Publication Top Notes 📚

  • Title: Cornual Pregnancy as a Rare Entity of Ectopic Pregnancy After Assisted Reproductive Therapy‐Embryo Transfer (ART‐ET): A Case ReportPublication: Clinical Case Reports
    Year: 2024
    ISSN: 2050-0904Authors: Hawraa Hassan Shbeeb

 

 

Xiaoning wang | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Xiaoning wang | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Xiaoning wang, Department of Hematology, The First Affiliated Hospital of Xi’an Jiaotong University, China

Dr. Xiaoning Wang serves as the Deputy Director at The First Affiliated Hospital of Xi’an Jiaotong University. With over 17 years of medical expertise, Dr. Wang is an Associate Chief Physician specializing in hematopoietic stem cell transplantation and immunotherapy. 🧬✨ He has led notable research projects, including advancements in acute T-cell leukemia treatment and NK cell reconstruction. Dr. Wang has published extensively in renowned journals like Blood and Nature Communications 🩸📚 and holds multiple patents. A leader in the field, he is a key figure in various medical associations, driving innovation and collaboration in hematology. 🌐🎓

 

Publication Profile

Orcid

Academic and Professional Background 🎓💼

Assoc. Prof. Dr. Xiaoning Wang has a rich medical career spanning over 17 years. He currently serves as an Associate Chief Physician (Jan 2017 – Present), where he oversees advanced hematology treatments and research. Previously, he worked as an Attending Physician (Mar 2012 – Dec 2016), gaining extensive expertise in patient care and clinical decision-making. His medical journey began as a Resident Doctor (July 2006 – Feb 2012), where he honed his foundational skills in diagnostics and treatment. Dr. Wang’s professional growth reflects his dedication to medical excellence and patient-focused innovation. 🏥🩺✨

 

Research Contributions

Assoc. Prof. Dr. Xiaoning Wang is a prominent researcher whose work spans hematology, oncology, and infectious diseases. Key studies include identifying the novel HLA-C*14:02:01:33 allele via advanced sequencing techniques, optimizing treatment regimens for severe pneumocystis pneumonia, and investigating high NK cell levels in grafts reducing febrile neutropenia post-transplantation. Her pivotal work on molecular biomarkers in multiple myeloma and graft-versus-host disease therapies showcases her innovative approach to immunology and stem cell research. Dr. Wang has significantly contributed to international medical knowledge, with publications in Nature Communications, Blood, and JAMA Ophthalmology. 📚✨

Publication Top Notes 📚

  • The novel HLA-C*14:02:01:33 allele identified by Pacific Biosciences HiFi sequencing in a Chinese individual.
  • A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.
  • Endogenous Aspergillus thermomutatus Endophthalmitis in a Patient With Myelodysplastic Syndrome.
  • High levels of NK Cells in graft are associated with reduced febrile neutropenia after haploidentical peripheral blood stem cell transplantation.
  • The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients.
  • Bloody tears as initial manifestation of rhino-orbital mucormycosis.
  • Pneumocystis jiroveci Pneumonia secondary to tyrosine kinase inhibitor with blinatumomab therapy: A case report.
  • ADAR1 improved Treg cell function through the miR-21b/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
  • Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils Novel Prognostic Biomarkers in Multiple Myeloma.
  • Acute myeloid leukemia secondary to acute B lymphoblastic leukemia treated with maintenance therapy in a child: A case report.
  • Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysis.